scispace - formally typeset
K

Ka-Wing Cheng

Researcher at Shenzhen University

Publications -  121
Citations -  5565

Ka-Wing Cheng is an academic researcher from Shenzhen University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 34, co-authored 103 publications receiving 4396 citations. Previous affiliations of Ka-Wing Cheng include The Chinese University of Hong Kong & Stony Brook University.

Papers
More filters
Journal ArticleDOI

Trapping Effects of Green and Black Tea Extracts on Peroxidation-Derived Carbonyl Substances of Seal Blubber Oil

TL;DR: EGCG's direct trapping of RCS may also contribute to the significant reduction of acrolein and other aldehydes in the peroxidation of seal blubber oil.
Journal ArticleDOI

6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells

TL;DR: It is demonstrated that 6-CEPN induces cell growth inhibition and cytoprotective autophagy in colon cancer cells, at least in part, though inhibition of the Icmt/RAS signalling pathways.
Journal ArticleDOI

Inhibition of autophagy modulates astaxanthin and total fatty acid biosynthesis in Chlorella zofingiensis under nitrogen starvation

TL;DR: This work has been the first to report a potentially important role of autophagy in fatty acid and astaxanthin accumulation in C. zofingiensis under stress conditions and suggests the potential involvement of post-transcriptional regulation in fatty acids biosynthesis.
Journal ArticleDOI

Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts

TL;DR: The novel phosphosulindac (OXT‐328, PS) selectively and effectively eliminates breast CSCs both in vitro and in vivo, and indicates that PS has a strong inhibitory effect against breast cancer.
Journal ArticleDOI

Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics

TL;DR: Results show that curcumin substantially improves the pharmacokinetics of PS leading to synergistic inhibition of the growth of human lung cancer xenografts, representing a promising drug combination.